Global Harmonization of Pediatric Drug Development: Critical for Progress for Developing Safe and Effective Therapeutic Agents for Children
| Autor: | Andrew E. Mulberg, MD, FAAP, Timothy Cripps, MSc |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: | |
| Zdroj: | Current Therapeutic Research, Vol 90, Iss , Pp 109-112 (2019) |
| Druh dokumentu: | article |
| ISSN: | 0011-393X 25622498 |
| DOI: | 10.1016/j.curtheres.2019.01.006 |
| Popis: | ABSTRACT: The article, ''Questionable Industry-Sponsored Studies in Children and Adolescents in Slovenia'' provides an opportunity to discuss evolving US and EU legislative measures to improve the available clinical trial-derived pediatric data and provide coherent labeling for pediatric providers in dosing of drugs for children. Keywords: Pediatric drug development, PIP, BPCA, PREA |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|